ArticleScience advances2022
ACTR5 controls CDKN2A and tumor progression in an INO80-independent manner.
Xiaobao Xu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
13 papers cite it
this papercites it
ArticleScience advances2022
Xiaobao Xu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.